<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00985205</url>
  </required_header>
  <id_info>
    <org_study_id>RE-ENERGIZE</org_study_id>
    <secondary_id>CIHR # 190808</secondary_id>
    <nct_id>NCT00985205</nct_id>
  </id_info>
  <brief_title>The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury</brief_title>
  <acronym>RE-ENERGIZE</acronym>
  <official_title>Effects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daren K. Heyland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Evaluation Research Unit at Kingston General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the following hypotheses:

        1. Enteral glutamine administration decreases in-hospital mortality in adult patients with
           severe thermal burn injuries.

        2. Enteral glutamine administration decreases hospital-acquired blood stream infections
           from Gram negative organisms and length of stay in ICU and hospital for adult patients
           with severe thermal burn injuries.

        3. Enteral glutamine administration will improve the physical function of surviving burn
           injured patients and reduce their cost of care.

      The objectives of this trial are to determine the overall treatment effect and safety of
      glutamine in burn patients. Specifically, the investigators want to assess the following
      outcomes in a sample of 2,700 patients in 80 sites:

        1. In patients with severe, life-threatening burn injury, what is the effect of enteral
           glutamine on 6 month mortality?

        2. In patients with severe, life-threatening burn injury, what is the effect of enteral
           glutamine on time to discharge alive from hospital, hospital-acquired blood stream
           infections from Gram negative organisms, hospital mortality, duration of stay in ICU and
           hospital, health-related quality of life, and health care resources?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Burn injuries represent a public health problem worldwide, ranked fourth in all injuries and
      are among the leading cause of disability adjusted life years in low and middle-income
      countries. More than in any other injury, the inflammation and catabolism associated with
      severe burns can exacerbate nutrient deficiencies, thereby predisposing patients to impaired
      immune function and increased risk of developing infectious complications, organ dysfunction,
      and death. Consequently, over the last few decades numerous trials have evaluated the impact
      of different nutrition/nutrient strategies in severe burns patients. Glutamine is of
      particular interest in this regard as it appears vital for a number of key stress-response
      pathways in serious illness. The existing randomized trials of glutamine supplementation in
      burns patients have suggested a significant reduction in mortality, infection, and hospital
      length of stay. However, in other critically ill patient populations, there is a signal of
      increased mortality associated with glutamine administration. Given this conflicting
      evidence, burn practitioners are either harming or saving lives with glutamine use. The
      purpose of the current proposal is to provide the rationale for a large, multicenter clinical
      trial of supplemental enteral glutamine in 2700 severe burn injury patients. We hypothesize
      that the inexpensive therapeutic strategy tested in this randomized controlled trial will
      lead to lower morbidity and mortality and reduced health care costs in an otherwise very
      devastating and disabling injury worldwide.

      In our pilot study (Critical Care Medicine, 2003, 31:2444) we found a protective effect of
      glutamine against blood infection in severely burned adult patients. In addition, a
      significant decrease in mortality was observed with glutamine. These results should be tested
      with a multi-center trial because our study was small and did not have mortality as an end
      point.

      The specific aims of the study are to determine the overall treatment effect and safety of
      glutamine in burn patients. Clinical outcomes will be: mortality, time to discharge alive,
      incidence of acquired bacteremia due to Gram negative organisms, hospital mortality, duration
      of mechanical ventilation, ICU stay and hospital stay. The cost-effectiveness of glutamine
      administration will also be measured if the results show a decrease in length of care or a
      reduced incidence of infections with glutamine.

      The study will be a large, multicenter, double-blind, pragmatic, randomized controlled trial
      of 2,700 patients with severe burns randomly allocated to receive enteral glutamine or
      placebo. Randomization will be concealed and stratified by site allocating patinets 1:1 to
      either glutamine or matching placebo by the method of permuted blocks of random undisclosed
      size within strata. Patients will be adults, a minimum of 18 years old, with deep 2nd and/or
      3rd degree burns requiring grafting, and for patients age 18 - 39 years a (Total Body Surface
      Area) TBSA burn ≥ 20% or in the presence of an inhalation injury a minimum of 15% TBSA burn
      is required; for patients age 40 - 59 years a TBSA burn &gt; 15% is required; for patients aged
      60 years or older a TBSA burn ≥ 10% is required. The study will include approximately 80 burn
      centers in Canada, the US, Europe and Latin America. Patients will receive glutamine or a
      placebo through their feeding tube, every 4 hours or TID if taking things by mouth, for a
      total of 0.5 g/kg/day for patients with a BMI &lt;35. Patients with a BMI &gt;35 will receive 0.5
      g/kg/day based on an obesity-adjusted body weight. The study intervention will be
      administered until &gt;7 days after the last successful grafting operation or until discharge
      from acute care unit or 3 months from admission, whichever comes first. Resuscitation,
      nutritional support, pain management, infection control and surgical care will be done
      according to standardized procedures.

      The Data will be collected and managed by a professional and centralized organization for
      multi centres clinical research (Clinical Evaluation Research Unit, Kingston, Ontario,
      Canada).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 Month Mortality</measure>
    <time_frame>6 Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Discharge Alive</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Health-Related Quality of Life - in particular the physical function domain of the SF-36, ADL, and IADL questionnaires.</measure>
    <time_frame>6 Month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of acquired bacteremia due to Gram negative organisms</measure>
    <time_frame>3 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Hospital Mortality</measure>
    <time_frame>3 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Duration of Mechanical Ventilation</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>ICU Stay</measure>
    <time_frame>3 Months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Hospital Stay</measure>
    <time_frame>3 Months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2700</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Enteral Glutamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5 g/kg/day mixed in water and given via nasogastric tube as boluses q 4 hrs or TID if po</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Mixed in with water and given via nasogastric tube as boluses q 4hrs or TID if po</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Enteral Glutamine</intervention_name>
    <description>0.5g/kg/day powdered glutamine to be mixed in with water and given via nasogastric tube q4 hrs or TID if po.</description>
    <arm_group_label>Enteral Glutamine</arm_group_label>
    <other_name>Glutamine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Maltodextrin mixed with water given via NG tube Q 4 hours or TID if po.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Maltodextrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Deep 2nd and/or 3rd degree burns requiring grafting

          2. Patient meets one of the following 4 criteria:

               1. Patients 18 - 39 years of age with ≥ 20% TBSA* burn

               2. Patients 18 - 39 years of age with ≥ 15% TBSA* burn and with inhalation injury

               3. Patients 40 - 59 years of age with ≥ 15% TBSA* burn

               4. Patients ≥ 60 years of age ≥ 10% TBSA* *TBSA - Total Body Surface Area

        Exclusion Criteria:

          1. &gt; 72 hrs from admission to ICU to time of consent.

          2. Patients younger than 18 years of age.

          3. a) Patients without known renal disease and renal dysfunction defined as a serum
             creatinine &gt;171 µmol/L or a urine output of less than 500 mL/last 24 hours (or 80
             mL/last 4 hours if a 24 hour period of observation is not available).

             b) Patients with acute on chronic renal failure (pre-dialysis) with an absolute
             increase of &gt;80 µmol/L from baseline or pre-admission creatinine or a urine output of
             &lt;500 mL/last 24 hours (or 80 mL/last 4 hours).

             c) Patients with chronic renal failure on dialysis will be excluded.

          4. Liver cirrhosis - Child-Pugh class C liver disease

          5. Pregnant or lactating females.

          6. Contra-indication for EN: intestinal occlusion or perforation, intra-abdominal injury.

          7. Patients with injuries from high voltage electrical contact.

          8. Patients who are moribund (not expected to survive the next 72 hours).

          9. Patients with extreme body sizes: BMI &lt; 18 or &gt; 50

         10. Enrollment in another industry sponsored ICU intervention study.

         11. Received glutamine supplement for &gt; 24 hrs prior to randomization

         12. Known allergy to maltodextrin, corn starch, corn, corn products or glutamine.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daren Heyland, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen's University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maureen Dansereau</last_name>
    <phone>613 549 6666</phone>
    <phone_ext>6686</phone_ext>
    <email>danserem@kgh.kari.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daren Heyland, MD</last_name>
    <email>dkh2@queensu.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arizona Burn Center at Maricopa Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Foster</last_name>
      <phone>602-344-5624</phone>
      <email>kevin_foster@dmgaz.org</email>
    </contact>
    <contact_backup>
      <last_name>Claudia Islas</last_name>
      <phone>602-344-1246</phone>
      <email>claudiaIslas@mihs.org</email>
    </contact_backup>
    <investigator>
      <last_name>Kevin Foster</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern California Regional Burn Ctr at LAC &amp; USC Med. Ctr.</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90089-9235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Warren Garner</last_name>
      <phone>613-540-1089</phone>
      <email>garner@surgery.usc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Pui Yan</last_name>
      <phone>323-442-5693</phone>
      <email>puiyan@med.usc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Warren Garner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shriners Hospitals for Children Northern California</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katrina Falwell</last_name>
      <phone>916-453-2050</phone>
      <email>kafalwell@ucdavis.edu</email>
    </contact>
    <investigator>
      <last_name>Tina Palmieri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Anesthesiology, University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arek Wiktor, MD</last_name>
      <phone>720-848-0000</phone>
      <email>arek.wiktor@ucdenver.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tyler Smith</last_name>
      <phone>720-848-5368</phone>
      <email>Tyler.2Smith@ucdenver.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Arek Wiktor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Connecticut Burn Center</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alisa Salvetamel</last_name>
      <phone>203-384-3998</phone>
      <email>alisa.savetamal@bpthosp.org</email>
    </contact>
    <contact_backup>
      <last_name>Deborah Lea Bandanza</last_name>
      <phone>203-384-3678</phone>
      <email>deborah.bandanza@bpthosp.org</email>
    </contact_backup>
    <investigator>
      <last_name>Alisa Salvetamel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Burn Center at Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20782</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jefferey Shupp</last_name>
      <phone>202-877-7347</phone>
      <email>Jeffery.W.Shupp@medstar.net</email>
    </contact>
    <contact_backup>
      <last_name>Melissa McLawhorn</last_name>
      <phone>202-877-0344</phone>
      <email>melissa.m.mclawhorn@medstar.net</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffery Shupp</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shands Burn Center at the University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Mozingo</last_name>
      <phone>352-273-5670</phone>
      <email>mozindw@surgery.ufl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tera Thigpin</last_name>
      <phone>352-265-0111</phone>
      <phone_ext>45824</phone_ext>
      <email>thera.thigpin@surgery.ufl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Mozingo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Florida/Tampa Gen. Hosp. Reg. Burn Center, FL</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Smith</last_name>
      <phone>813-974-7096</phone>
      <email>dsmith3@health.usf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rachel Karlnoski</last_name>
      <phone>813-844-4133</phone>
      <email>rkarlnos@health.usf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Smith</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joseph M Still Burn Center</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce Friedman, MD</last_name>
      <phone>706-364-2966</phone>
      <email>pmcdade@acutecareconsultants.net</email>
    </contact>
    <contact_backup>
      <last_name>M. Anwarhul H Mian, MD, PhD, MPH</last_name>
      <phone>706-364-2966</phone>
      <email>Mah.Mian@jmsburncenters.com</email>
    </contact_backup>
    <investigator>
      <last_name>Bruce Friedman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Surgery University of Iowa Hospitals &amp; Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucy Wibbenmeyer, MD</last_name>
      <phone>319-353-8435</phone>
      <email>Lucy-wibbenmeyer@uiowa.edu</email>
    </contact>
    <contact_backup>
      <last_name>Brian Grieve</last_name>
      <phone>319-356-1304</phone>
      <email>brian.grieve@uiowa.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Lucy Wibbenmeyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Pollack, MD</last_name>
      <phone>314-251-5570</phone>
      <email>jonathan.pollack@mercy.net</email>
    </contact>
    <contact_backup>
      <last_name>Mary Wilcox, RN, BSN</last_name>
      <phone>314-251-7899</phone>
      <email>mary.wilcox@mercy.net</email>
    </contact_backup>
    <investigator>
      <last_name>Jonathan Pollack, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Elizabeth Regional Burn Center</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68150</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Voigt</last_name>
      <phone>402-483-7825</phone>
      <email>dwvoigt@neb.rr.com</email>
    </contact>
    <contact_backup>
      <last_name>Karri Donahue</last_name>
      <phone>1-402-219-7936</phone>
      <email>kdonahue1@stez.org</email>
    </contact_backup>
    <investigator>
      <last_name>David Voigt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198-7835</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Holmes</last_name>
      <phone>336-716-0549</phone>
      <email>jholmes@wakehealth.edu</email>
    </contact>
    <contact_backup>
      <last_name>William Martin</last_name>
      <phone>336-716-1659</phone>
      <email>wmartin@wakehealth.edu</email>
    </contact_backup>
    <investigator>
      <last_name>James Holmes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Akron's Children's Hospital, Paul &amp; Carol David Foundation</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308-1062</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Crow</last_name>
      <phone>330-543-4586</phone>
      <email>Jcrow@chmca.org</email>
    </contact>
    <contact_backup>
      <last_name>Deb maglionico</last_name>
      <phone>330-543-0847</phone>
      <email>dmaglionica@chmca.org</email>
    </contact_backup>
    <investigator>
      <last_name>John Crow</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexnar Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Larry Jones</last_name>
      <phone>614-293-5710</phone>
      <email>larry.jones@osumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rebecca Coffey</last_name>
      <phone>614-685-6374</phone>
      <email>rebecca.coffey@osumc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Larry Jones</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Legacy Emmanuel Hospital &amp; Health Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathan A Kemalyan, MD</last_name>
      <phone>503-413-4232</phone>
      <email>NKemalya@lhs.org</email>
    </contact>
    <contact_backup>
      <last_name>Kristin Hickey</last_name>
      <phone>503-413-5447</phone>
      <email>khickey@lhs.org</email>
    </contact_backup>
    <investigator>
      <last_name>Nathan A Kemalyan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Western Pennsylvania Hospital Burn Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ariel Abbalay</last_name>
      <phone>412-578-1836</phone>
      <email>aaballay@wpahs.org</email>
    </contact>
    <contact_backup>
      <last_name>Ben Kelly</last_name>
      <phone>412-578-5748</phone>
      <email>ben.kelly@ahn.org</email>
    </contact_backup>
    <investigator>
      <last_name>Ariel Aballay</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Tennessee Health Science Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Hickerson</last_name>
      <phone>901-448-2579</phone>
      <email>whicker1@uthsc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Angela Arnold-Ross</last_name>
      <phone>901-302-2480</phone>
      <email>aarnoldr@uthsc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>William Hickerson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-9020</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Wolf, MD</last_name>
      <phone>214-648-2041</phone>
      <email>steven.wolf@utsouthwestern.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ariza Sisavath</last_name>
      <phone>214-648-7200</phone>
      <email>ariza.sisavath@utsouthwestern.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Wolf</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>JBSA Fort Sam Houston</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234-7767</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Ferguson, RC</last_name>
      <email>Amanda.r.ferguson2.ctr@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Jennifer Gurney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Herndon</last_name>
      <phone>409-770-6733</phone>
      <email>dherndon@UTMB.EDU</email>
    </contact>
    <contact_backup>
      <last_name>Deb Benjamin</last_name>
      <phone>409-770-6740</phone>
      <email>dbenjami@utmb.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Herndon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann/UTHSC</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Cross</last_name>
      <phone>713-500-7181</phone>
      <email>James.M.Cross@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Garrett Jost</last_name>
      <phone>214-641-2179</phone>
      <email>Garrett.B.Josh@uth.tms.edu</email>
    </contact_backup>
    <investigator>
      <last_name>James Cross</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harbourview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195-9796</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sam Mandell</last_name>
      <phone>206-744-3410</phone>
      <email>mantels@uw.edu</email>
    </contact>
    <contact_backup>
      <last_name>Shari Honari</last_name>
      <phone>1-206-744-3587</phone>
      <email>shonari@uw.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Sam Mandell</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia-St. Mary's, Milwaukee, Wi</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Meyer</last_name>
      <phone>414-319-3000</phone>
      <email>meyernamu@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Patricia Haugh</last_name>
      <phone>1-414-585-1148</phone>
      <email>phaugh@columbia-stmarys.org</email>
    </contact_backup>
    <investigator>
      <last_name>Nicholas Meyer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia St. Mary's</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Meyer</last_name>
      <phone>414-319-3000</phone>
      <email>nicholas.meyer@columbia-stmarys.org</email>
    </contact>
    <contact_backup>
      <last_name>Patricia Haugh</last_name>
      <phone>414-585-1148</phone>
      <email>phaugh@columbia-stmarys.org</email>
    </contact_backup>
    <investigator>
      <last_name>Nicholas Meyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daisy Vermeiren, RC</last_name>
      <email>daisy.vermeiren@uzgent.be</email>
    </contact>
    <investigator>
      <last_name>Kirsten Colpaert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marjorie Fadeur, RC</last_name>
      <email>marjorie.fadeur@chu.ulg.ac.be</email>
    </contact>
    <investigator>
      <last_name>Anne-Françoise Rousseau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Calgary Firefighters' Burn Unit</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Stelfox, MD</last_name>
      <phone>403-944-0742</phone>
      <email>tstelfox@ucalgary.ca</email>
    </contact>
    <contact_backup>
      <last_name>Stacy Ruddell</last_name>
      <phone>403-944-8748</phone>
      <email>stacy.Ruddell@albertahealthservices.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Tom Stelfox</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Health Sciences Centre Burn Unit, Winnipeg</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sarvesh Logsetty</last_name>
      <email>logsetty@cc.umanitoba.ca</email>
    </contact>
    <investigator>
      <last_name>Sarvesh Logsetty</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HHS/Hamilton Firefighters Burn Unit</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arianna Dal Cin</last_name>
      <phone>905-526-0811</phone>
      <email>dalcin@hhsc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Natalie Hanna</last_name>
      <phone>905-521-2100</phone>
      <phone_ext>46347</phone_ext>
      <email>hanna@hhsc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Ariana Dal Cin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Jeschke, MD</last_name>
      <phone>416-480-6703</phone>
      <email>marc.jeschke@sunnybrook.ca</email>
    </contact>
    <contact_backup>
      <last_name>Leslie Summers</last_name>
      <phone>416-480-6100</phone>
      <phone_ext>7998</phone_ext>
      <email>leslie.summersdeluca@sunnybrook.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Marc Jeschke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHUM/Centre des Grands Brules</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X 0A9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvain Belisle</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>84444</phone_ext>
      <email>Sylvain.Belisle@sympatico.ca</email>
    </contact>
    <contact_backup>
      <last_name>Fatna Benettaib</last_name>
      <phone>514-387-4662</phone>
      <email>fatna.benettaib.chum@ssss.gouv.qc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Sylvain Belisle</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HEJ/Centre des Grands Brules</name>
      <address>
        <city>Quebec</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexis Turgeon</last_name>
      <phone>418-649-0252</phone>
      <phone_ext>66064</phone_ext>
      <email>alexis.turgeon@fmed.ulaval.ca</email>
    </contact>
    <contact_backup>
      <last_name>Marie-Claude Tremblay</last_name>
      <phone>418-649-0252</phone>
      <phone_ext>66060</phone_ext>
      <email>Marie-Claude.Tremblay@crchudequebec.ulaval.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Alexis Turgeon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Tecnologico de Santo Domingo</name>
      <address>
        <city>Santo Domingo</city>
        <zip>10602</zip>
        <country>Dominican Republic</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>RWTH Aachen University</name>
      <address>
        <city>Aachen</city>
        <state>North Rhine-Westphalia</state>
        <zip>52062</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carina Benstoem, RC</last_name>
      <phone>0241 80-36575</phone>
      <email>cbenstoem@ukaachen.de</email>
    </contact>
    <investigator>
      <last_name>Christian Stoppe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Central &quot;Dr. Ignacio Morones Prieto</name>
      <address>
        <city>San Luis Potosi</city>
        <state>San Luis Potosí</state>
        <zip>78000</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mercedes Yanes, MD</last_name>
      <phone>444 8342700</phone>
      <email>mercedesyanes9@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mario Martínez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Civil Fray Antonio Alcalde</name>
      <address>
        <city>Guadalajara</city>
        <zip>44280</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guadalupe Aguirre, MD</last_name>
      <phone>3340401508</phone>
      <email>gaguirre@cencar.udg.mx</email>
    </contact>
    <investigator>
      <last_name>Miguel Ibarra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Nacional de Quemaduras y Cirugia Reconstructiva</name>
      <address>
        <city>Asunción</city>
        <country>Paraguay</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daisy Grau, MD</last_name>
      <phone>595981465855</phone>
      <email>daigrau@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Daisy Grau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Vicente, RC</last_name>
      <phone>96 124 67 11</phone>
      <phone_ext>246711</phone_ext>
      <email>diana_vicente@iislafe.es</email>
    </contact>
    <investigator>
      <last_name>Carmen Vivo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>75124</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Lindblad, RC</last_name>
      <phone>46 76 496 39 13</phone>
      <email>marie.lindblad@akademiska.se</email>
    </contact>
    <investigator>
      <last_name>Fredrik Huss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Birmingham NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <state>Edgbaston</state>
        <zip>B15 2GW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liesl Despy, RN</last_name>
      <phone>07766070945</phone>
      <email>Liesl.Despy@uhb.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Naiem S Moiemen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Helens &amp; Knowsley Teaching Hospitals</name>
      <address>
        <city>Liverpool</city>
        <state>England</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel George, MD</last_name>
      <email>Samuel.George@sthk.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Kayvan Shokrollahi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chelsea and Westminster Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>SW10 9NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vasiliki Dekou, RC</last_name>
      <email>Vasiliki.Dekou@chelwest.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Declan Collins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newcastle upon Tyne Hospitals</name>
      <address>
        <city>Newcastle Upon Tyne</city>
        <state>England</state>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leigh Dunn, RC</last_name>
      <email>Leigh.Dunn@nuth.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Ian Clement, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Dominican Republic</country>
    <country>Germany</country>
    <country>Mexico</country>
    <country>Paraguay</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Australia</country>
  </removed_countries>
  <link>
    <url>http://www.criticalcarenutrition.com</url>
    <description>Related Info</description>
  </link>
  <reference>
    <citation>Garrel D, Patenaude J, Nedelec B, Samson L, Dorais J, Champoux J, D'Elia M, Bernier J. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med. 2003 Oct;31(10):2444-9.</citation>
    <PMID>14530749</PMID>
  </reference>
  <reference>
    <citation>Zhou YP, Jiang ZM, Sun YH, Wang XR, Ma EL, Wilmore D. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr. 2003 Jul-Aug;27(4):241-5.</citation>
    <PMID>12903886</PMID>
  </reference>
  <reference>
    <citation>Peng X, Yan H, You Z, Wang P, Wang S. Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients. Burns. 2004 Mar;30(2):135-9.</citation>
    <PMID>15019120</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2009</study_first_submitted>
  <study_first_submitted_qc>September 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2009</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Evaluation Research Unit at Kingston General Hospital</investigator_affiliation>
    <investigator_full_name>Daren K. Heyland</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Randomized Clinical Trial</keyword>
  <keyword>Glutamine</keyword>
  <keyword>Themal Burn Injuries</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Outcome Assessment</keyword>
  <keyword>Critical Care</keyword>
  <keyword>Total Body Surface Area</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

